Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Size By Product (Sutures, Implants), By End User (Healthcare Providers, Biotech Firms), By Applications (Medication Delivery, Tissue Engineering), By Geographic Scope And Forecast

Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Size And Forecast

Poly (Lactic-Co-Glycolic Acid) (PLGA) Market size was valued at USD 0.825 Billion in 2023 and is projected to reach USD 2.4 Billion by 2030, growing at a CAGR of 13.2% during the forecast period 2024-2030.

Okay, so the market for PLGA is really taking off, and a big reason is that pharmaceutical and biotech companies are clamoring for it. PLGA is super versatile – it plays well with the body, breaks down naturally, and we can even tweak how fast it degrades. That’s why you see it everywhere, from drug delivery systems to tissue engineering and even inside medical devices. And get this, Asia Pacific, especially places like China and India, are expected to see the biggest jump in growth. Think increased healthcare spending and a growing need for those advanced medical gadgets. Finally, all these folks making PLGA-based nanoparticles and microparticles for drug delivery? They're about to see some serious opportunities.

Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Definition

The pharmaceutical and biological sectors make extensive use of the compostable material poly (lactic-co-glycolic acid) or PLGA. It is a mixture of lactic acid and glycolic acid, the ratio between which can be altered to affect characteristics like tensile strength and rate of decomposition. Because of its biocompatibility and biodegradability, PLGA is a great choice for use in medical equipment, tissue engineering, and medication transport systems. Pharmaceutically active poly (lactic acid) (PLGA) drug delivery devices encase and transport medicines to specific locations in the body.

Drug effectiveness reduced adverse effects, and patient compliance can all improve as the PLGA polymer dissolves and the drug is released gradually over time. Scaffolds for tissue development and repair can be made out of PLGA in the field of tissue engineering. Mechanical characteristics like rigidity and permeability can be tailored in PLGA-based structures to affect cell behaviour and tissue regrowth. Due to their biocompatibility and biodegradability, PLGA-based medical products like stitches, implants, and tubes are also rising in favor.

Good news! Because your body slowly absorbs PLGA sutures, you won't need to have them taken out after surgery. And implants or tubes made from PLGA? They break down naturally over time. This is great because it reduces the risk of complications and means fewer follow-up procedures. The Poly (Lactic-Co-Glycolic Acid) (PLGA) Market is really taking off, driven by the increasing need for biodegradable materials in healthcare, plus lots of research and development happening in medication delivery systems and tissue engineering. Things like technological progress, more money being spent on research, and people understanding how useful biodegradable plastics are in healthcare are all playing a big role. Some of the big players in the PLGA world include Evonik Industries AG, Corbion N.V., the Shandong Institute of Medical Instruments, and Sigma-Aldrich Corporation.

Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Overview

Due to its biocompatibility and biodegradability, poly (lactic-co-glycolic acid) (PLGA) has found widespread application in the pharmaceutical and biomedical sectors. Physical and chemical qualities, such as degradation rate and mechanical strength, may be tailored by altering the composition of PLGA, a copolymer of lactic acid and glycolic acid. Due to the rising demand for biodegradable polymers in the healthcare sector, the Poly (Lactic-Co-Glycolic Acid) (PLGA) Market has expanded fast in recent years.

Several different therapeutic fields have made extensive use of drug delivery systems based on PLGA, including cancer, cardiovascular illness, and neurological disorders. Better patient outcomes may result from the regulated release of medications using PLGA-based systems because of increased effectiveness and decreased adverse effects. Many gene therapies and vaccines have been created with the use of PLGA-based drug delivery systems.PLGA is not only employed in drug delivery systems but also in tissue engineering.

Scaffolds made from polylactic acid (PLGA) have been utilized to foster the development and repair of skin, cartilage, and bone. PLGA scaffolds may be used to repair or replace damaged tissues because their mechanical characteristics can be adjusted to meet the needs of individual tissue types. Due to their biocompatibility and biodegradability, PLGA-based medical products like stitches, implants, and tubes are also rising in favour. Because the body gradually absorbs PLGA sutures, surgical removal of the sutures is unnecessary.

Implants and tubes made from PLGA biodegrade over time, minimizing the potential for illness and the need for additional procedures. During the projected period, the Poly (Lactic-Co-Glycolic Acid) (PLGA) Market is anticipated to expand at a pace of fastest in the Asia Pacific region. The expansion of the Poly (Lactic-Co-Glycolic Acid) (PLGA) Market in the Asia Pacific is anticipated to be driven by rising demand for cutting-edge healthcare technology in developing nations like China and India.

Growth in the Poly (Lactic-Co-Glycolic Acid) (PLGA) Market is further aided by the presence of large pharmaceutical and biomedical firms in North America and Europe. numerous well-established companies and numerous up-and-coming startups all compete fiercely in the PLGA industry. Evonik Industries AG, Corbion N.V., Shandong Institute of Medical Instruments, Sigma-Aldrich Corporation, and Wako Pure Chemical Industries, Ltd. are only a few of the major competitors in the Poly (Lactic-Co-Glycolic Acid) (PLGA) Market.

These businesses are attempting to boost their market share by developing new goods, forming strategic alliances, and collaborating with other businesses. The high price of PLGA-based goods, scarcity of raw materials, and severe regulatory requirements are just a few of the obstacles the PLGA business must overcome. These obstacles are projected to be addressed and the expansion of the Poly (Lactic-Co-Glycolic Acid) (PLGA) Market is fuelled by the creation of new and innovative products, improvements in technology, and rising investment in R&D over the coming years.

Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Segmentation Analysis

The Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market is Segmented on the basis of Product, End User, Applications, And Geography.

Poly (Lactic-Co-Glycolic Acid) (PLGA) Market, By Product

• Sutures
• Implants
• Stents

Based on Product, the market is segmented into Sutures, Implants, and Stents. The market for PLGA also includes medical equipment. Because of its biocompatibility and biodegradability, PLGA-based medical products such as sutures, implants, and stents are becoming more common. Because the body gradually absorbs PLGA sutures, surgical removal of the sutures is unnecessary. Implants and tubes made from PLGA biodegrade over time, minimizing the potential for illness and the need for additional procedures.

Poly (Lactic-Co-Glycolic Acid) (PLGA) Market, By End User

• Healthcare Providers
• Biotech Firms
• Universities
• Others

Based on End User, the market is segmented into Healthcare Providers, Biotech Firms, Universities, and Others. In 2020, the pharmaceutical and biotechnology sector was the major consumer of PLGAs, and this trend is anticipated to continue through 2025. This is because the healthcare sector is increasingly interested in PLGA-based medication delivery systems and medical devices.

Poly (Lactic-Co-Glycolic Acid) (PLGA) Market, By Applications

• Medication Delivery
• Tissue Engineering
• Medical Devices

Poly (Lactic-Co-Glycolic Acid) (PLGA) Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of The World

On the basis of Geography, the Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market is classified into North America, Europe, Asia Pacific, And Rest of The World. The concentration of leading pharmaceutical and biomedical firms in North America explains the region’s market dominance. The increasing demand for PLGA-based products in the healthcare sector in Europe has made the region a significant player in the PLGA market. Due to increased investments in healthcare and growing demand for sophisticated medical technology in developing countries like China and India, the Asia Pacific region is predicted to have the largest growth throughout the projected period.

Key Players

The “Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market” study report will provide a valuable insight with an emphasis on the global market. The major players in the market are Evonik Industries AG, Corbion N.V., PolySciTech (Akina, Inc.), Shandong Keyuan Pharmaceutical Co., Ltd., LACTEL Absorbable Polymers (Durect Corporation), Wego Chemical Group, Green Polymer Corporation, Kureha Corporation, Jinan Daigang Biomaterial Co., Ltd., and Sigma-Aldrich Corporation.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

• 2019 – Corbion NV, a global leader in biodegradable polymer innovation, introduced a new PLA-based platform in 2019. Companies may now modify PLA and PLA/PLGA blends for enhanced performance and processing capabilities using this technology.
• 2020 – In 2020, Evonik Industries AG introduced a new resomer based on PLGA for use in the medical field. This PLGA/PEG resomer was developed with the goals of regulated medication release and inflammation suppression.
• 2020 – LACTEL Absorbable Polymers (Durect Corporation) launched Posimir®, a PLGA-based postoperative pain medication, in 2020 after receiving FDA clearance. The postoperative pain medication Posimir® is an extended-release version of the anaesthetic bupivacaine.
• 2021 – PolySciTech (Akina, Inc.) released the PolyVivo AK110, a medication delivery system based on poly(lactic-co-glycolic acid), in 2021. The goal of this method of administering medication is to allow for gradual, steady drug release over the course of many weeks or months.
• 2021 – To fulfil the rising demand for biodegradable polymers in the healthcare business, Shandong Keyuan Pharmaceutical Co., Ltd. stated in 2020 that it will increase its PLGA manufacturing capacity in 2021.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We take a good look at the market, using both numbers and real-world stuff to understand different groups of customers.

• We'll give you the market size in USD Billion for each part of the market.
• We'll point out which areas and customer groups are likely to grow the fastest and be the biggest.

• Who's on top?
• What new things have they launched?
• Who's partnering with whom?
• Who's expanding or buying other businesses? (We'll cover the last five years.)

• An overview
• Key insights
• How their products stack up
• A SWOT analysis

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.